|
Appropriate xenograft models can be quickly determined by screening
our XenoSelect Panel. Each cell line has been well validated
in house for xenograft model, so that customers can move from
in vitro phase to in vivo efficacy testing without any delay.
| Cancer
type |
Cell
lines |
| Breast
cancer |
MCF-7, MDA-MB231,
SKBR3, BT474, MCF-7-218 (Her2++) |
| Lung
cancer |
A549, NCI-H460, NCI-H226 , SK-MES1, Calu6 |
| Colorectal
cancer |
HT-29, HCT-116,DLD-1,
SW620, LoVo, Colo205, H1975 |
| Prostate
cancer |
DU-145, PC-3, LNCaP |
| Pancreatic
cancer |
MIAPACA-2, Bx-PC-3,
PANC-1 |
| Liver
cancer |
HepG2, SK-HEP-1, Hep3B |
| Melanoma |
A375, SK-MEL-5 |
| Ovarian
cancer |
SKOV3, OVCAR3 |
| Glioblastoma |
U87MG, LN-229 |
| Leukemia |
K562, HL60 |
| Multiple
myeloma |
RPMI 8226, OPM2 |
| Kidney
cancer |
786-O |
| Fibrosarcoma |
HT-1080 |
| Osteosarcoma |
143b |
| Gastric
cancer |
MGC803, BGC823,
NCI-N87 |
| H&N
cancer |
CNE2 |
| Oral
cancer |
KB |
|
